Interactive Q&A: Paul Sylvester, CEO of Manatron Inc. (MANA) [View article]
Paul, You're in 30 states and two Canadian territories. Do you see your growth prospects greatest in the US or in international markets? I think TYL is your publicly-traded competitor. They're much bigger than you. How can you compete with them over the long haul? I guess my question is what is your competitive advantage? Cheers, Sam
Sort by:
Latest | Highest ratedInteractive Q&A: Paul Sylvester, CEO of Manatron Inc. (MANA) [View article]
You're in 30 states and two Canadian territories. Do you see your growth prospects greatest in the US or in international markets?
I think TYL is your publicly-traded competitor. They're much bigger than you. How can you compete with them over the long haul? I guess my question is what is your competitive advantage?
Cheers,
Sam
Interactive Q&A: Daniel Montano, Chairman, President and CEO of CardioVascular BioTherapeutics Inc. (CVBT.OB) [View article]
Thanks for your time.
Two questions:
Where are you in the patent process?
Can you discuss leading drug candidates at CVBT?
All the best,
Ian